Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
3 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
bioAffinity Technologies closed a previously announced registered direct offering and concurrent private placement that raised about $4 million before fees and expenses. The company said it plans to use the net proceeds for working capital, CyPath Lung sales support and general corporate purposes.
bioAffinity Technologies said it closed a registered direct offering and concurrent private placement priced at-the-market under Nasdaq rules. The company said gross proceeds were about $4 million before fees and expenses.
bioAffinity Technologies said it closed its previously announced registered direct offering of common stock and a concurrent private placement priced at-the-market under Nasdaq rules.